European equities traded in the US as American depositary receipts were trending lower in late Tuesday morning trading, declining 0.50% to 1,960.50 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by software firm SAP (SAP) and pharmaceutical company Sanofi (SNY), which increased 1.7% and 1.6% respectively. They were followed by healthcare tech company Royal Philips (PHG) and biopharmaceutical company DBV Technologies (DBVT), which were up 1.5% and 1.3% respectively.

The decliners from continental Europe were led by telecommunications company Nokia (NOK) and biopharmaceutical company Cellectis (CLLS), which lost 3.8% and 2.9% respectively. They were followed by biotech firm Evaxion (EVAX) and furniture maker Natuzzi (NTZ), which dropped 1.6% and 1.5% respectively.

The gainers from the UK were led by software firm Endava (DAVA) and communications company WPP (WPP), which advanced 4.1% and 2.6% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and biotech company Trinity Biotech (TRIB), which rose 1.8% and 1.4% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which fell 2.5% and 2.4% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and lender Barclays (BCS), which were down 2.2% and 1.7% respectively.